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Background and Aims: Combined multichannel intraluminal
impedance and esophageal manometry (MII-EM) measures con-
comitantly bolus transit and pressure changes allowing determi-
nation of the functional impact of esophageal motility abnormal-
ities. Ten years ago our laboratory reported MII-EM results in 350
consecutive patients. Since then high-resolution impedance man-
ometry (HRIM) became available and the deﬁnitions of ineﬀective
esophageal motility (IEM) and nutcracker esophagus were revised.
The aim of this study was to assess the impact of these develop-
ments on esophageal function testing.
Methods: From August 2012 through May 2013, HRIM was per-
formed in 350 patients referred for esophageal function testing.
Each patient received 10 liquid and 10 viscous swallows. While
taking advantage of the new technology and revised criteria,
HRIM ﬁndings were classiﬁed according to the conventional cri-
teria to allow more appropriate comparison with our earlier
analysis.
Results: Compared with the study performed 10 years ago, the
prevalence of normal manometry (36% vs. 35%), achalasia (7% vs.
8%), scleroderma (1% vs. 1%), hypertensive lower esophageal
sphincter (LES) (7% vs. 7%), and hypotensive LES (1% vs. 2%)
remained the same, whereas the prevalence of distal esophageal
spasm (9% vs. 3%), nutcracker esophagus (9% vs. 3%), and poorly
relaxing LES (10% vs. 3%) decreased and the prevalence of IEM
increased (20% vs. 31%) signiﬁcantly. Compared with the early
study, normal liquid bolus transit was signiﬁcantly diﬀerent in
patients with hypertensive LES (96% vs. 57%) and poorly relaxing
LES (55% vs. 100%).
Conclusions: This study brings to light the increase in prevalence of
IEM. In addition, it suggests that the hypertensive LES and poorly
relaxing LES may each aﬀect bolus transit in about half of these
patients.
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Combined multichannel intraluminal impedance andmanometry (MII-EM) is a test of esophageal function
that provides concomitant evaluation of bolus transit and
pressure changes. First described by Silny in 1991, MII uses
diﬀerences in resistance to alternating currents among air,
esophageal mucosa, and esophageal liquid bolus to detect
bolus movement within the esophagus without the use of
radiation.1 Impedance is a useful addition to traditional
esophageal liquid manometry testing as it provides bolus
transit information in addition to pressure data, and nor-
mal values have been established for MII-EM.2 The clas-
siﬁcation of esophageal motility abnormalities has evolved
since Spechler and Castell’s original classiﬁcation based on
manometry alone in 2001,3 speciﬁcally the diagnostic cri-
teria of ineﬀective esophageal motility (IEM) and the nut-
cracker esophagus have become more stringent.4,5 Fur-
thermore, high-resolution impedance manometry (HRIM),
through more closely spaced pressure sensors along the
catheter, allows more detailed measurements of the intra-
luminal pressures and through the color-coded pressure
topography, provides a more accurate evaluation of the
lower esophageal sphincter (LES) dynamics following
deglutition.
The interpretation of HRIM is still being reﬁned.
Because the data gathered from the pressure topography is
user dependent, many clinicians convert the topography
display back to convention line tracings. Thus, using all the
tools available with this exciting technique allows for a
more standardized measurement and ease in establishing a
diagnosis.
Ten years ago, 350 consecutive patients were evaluated
in the Medical University of South Carolina esophageal
motility laboratory for functional abnormalities using
combined conventional MII-EM with intraluminal trans-
ducers at 5-cm intervals.6 The aim of the current study was
to evaluate and update the demographics and prevalence of
the various manometric disorders with the updated deﬁ-
nitions of IEM and the nutcracker esophagus, in addition
to the increased accuracy provided by HRIM technology.
METHODS
This study retrospectively examined 350 consecutive
prospectively collected HRIM studies performed in the
esophageal laboratory at the Medical University of South
Carolina from August 3, 2012 to May 15, 2013. Approval
was obtained from our Institutional Review Board to
review and analyze these studies and to publish the infor-
mation obtained from them. All patients included in the
study provided informed consent, giving the investigators
permission to use their data for database research studies.
Esophageal function testing was performed using a
UNI-ESO-WG1A1 High-Resolution Impedance Man-
ometry Probe (Sandhill Scientiﬁc Inc., Highlands Ranch,
CO). The UNI-ESO-WG1A1 HRIM catheter has a 4mm
diameter and includes 32 circumferential pressure channels
and 16 impedance channels. Solid state intraluminal pres-
sure transducers are located at 6, 4, 3, 2, 1, 0, 1,
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2, 3, 4, 5, 6, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 19, 20, 21, 23,
24, 25, 26, 27, 28, 29, and 30 cm and impedance-measuring
segments at 5, 3, 1, 1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21,
23, and 25 cm. The catheter was passed transnasally so that
the zero point on the catheter was aligned with the maximal
high-pressure zone of the LES. In the supine position,
patients received 10 swallows of 5mL normal saline and 10
swallows of 5mL viscous (apple sauce–like consistency)
material each 20 to 30 seconds apart. The HRIM software
can display data in either color-coded pressure topography
Clouse plots or traditional waveform line plots. In this
study, all data were acquired and visually assessed by
HRIM, but numerically analyzed using conventional
waveform line plots and interpreted using conventional
manometry normals to standardize data analysis for com-
parison with our prior study of diagnostic distribution a
decade earlier.6
Manometric parameters used to characterize swallows
included: (1) contraction amplitude at 5 and 10 cm above
the LES; (2) distal esophageal amplitude (DEA) as the
average of contraction amplitude at 5 and 10 cm above the
LES; and (3) onset velocity of esophageal contractions in
the distal part of the esophagus (ie, contraction velocity
between 10 and 5 cm above the LES). Mid-respiratory
resting pressure and LES residual pressure during swal-
lowing were used to assess LES function. Impedance
parameters included (1) bolus entries and exits 5, 10, 15,
and 20 cm above the LES; and (2) total bolus transit time
(TBTT), the time elapsed between bolus entry at 20 cm
above the LES and bolus exit at 5 cm above the LES.
Swallows were classiﬁed by manometry as (1) normal,
if the contraction amplitudes 5 and 10 cm above the LES
were each Z30mm Hg and the distal-onset velocity was
<8 cm/s; (2) ineﬀective, if either of the contraction ampli-
tudes at 5 or 10 cm above the LES was <30mm Hg; or (3)
simultaneous, if the contraction amplitudes at 5 and 10 cm
above the LES were each Z30mm Hg and the distal-onset
velocity was >8 cm/s.
Swallows were classiﬁed by MII as showing complete
bolus transit if bolus entry occurred at 20 cm above the
LES; bolus exit points were recorded in the 3 distal impe-
dance-measuring sites at 15, 10, and 5 cm above the LES,
and the TBTT was <15 seconds. A swallow was classiﬁed
as incomplete bolus transit if bolus exit was not identiﬁed at
any of the 3 distal impedance-measuring sites, if bolus entry
was not identiﬁed at 20 cm above the LES, or if the TBTT
was >15 s. Overall, esophageal transit was deﬁned as
normal liquid transit if at least 80% of liquid swallows had
complete bolus transit and as normal viscous transit if at
least 70% of viscous swallows had complete bolus transit.2
Manometry was evaluated for liquid swallows only
because that has been standard worldwide for many years.
Bolus transit, however, was evaluated for both liquid and
viscous swallows. Diagnoses of manometric motility
abnormalities for 8 “named” entities were established using
the original criteria published by Spechler and Castell,3
along with the more recently suggested changes in diag-
nostic criteria for IEM4 and the nutcracker esophagus.5
Achalasia was deﬁned by absent esophageal body peri-
stalsis and if present, poorly relaxing LES (residual pressure
>8mm Hg). The occasional hypertensive resting LES
pressure reinforced this diagnosis. Scleroderma (SSc) was
deﬁned based on an appropriate clinical diagnosis and
conﬁrmed by low-amplitude contractions in the distal
esophagus with or without a low LES pressure. Distal
esophageal spasm (DES) was deﬁned as Z20% simulta-
neous contractions. IEM was deﬁned as Z50% swallows
with contraction amplitude of <30mm Hg in either of the
2 distal sites located at 5 and 10 cm above the LES. Mild
IEM was deﬁned by associated normal bolus transit for
both liquid and viscous swallows, moderate IEM by
abnormal bolus transit for either liquid or viscous swallows,
and severe IEM by abnormal bolus transit for both liquid
and viscous swallows. Nutcracker esophagus was deﬁned as
normal peristalsis of the esophageal body with an average
DEA exceeding 220mm Hg. Poorly relaxing LES was
deﬁned as average LES residual pressure exceeding 8mm
Hg associated with normal esophageal body contractions.
Hypertensive LES was deﬁned as an LES mid-respiratory
resting pressure exceeding 45mm Hg with normal esoph-
ageal body contractions. Normal esophageal manometry
was deﬁned as no more than 40% ineﬀective swallows, no
more than 10% simultaneous swallows, a DEA<220mm
Hg, and a normal LES resting and residual pressures. In
patients having both esophageal body and LES abnor-
malities, the ﬁnal diagnosis was based on the esophageal
body ﬁnding.
Major motility abnormality (MMA) is a MII-EM
diagnosis that has evolved in our laboratory over the past
10 years; that is, since our prior report on diagnostic ﬁnd-
ings in the initial group of 350 patients. It is reserved for
patients whose motility study is clearly abnormal but dif-
ﬁcult to simply categorize into one of the 8 “named”
motility abnormalities. It is also intended to inform the
referring physician that the study is deﬁnitely abnormal.
The ﬁnal diagnosis on the report reads as “Major motility
abnormality with features of – and –” and may include any
combination of the following: achalasia, SSc, IEM, DES, or
nutcracker esophagus. It is intended to be used
sparingly. Figure 1 is a pressure tracing in which 90% of
swallows show failed peristalsis, 10% of swallows are
ineﬀective, and there is a normal residual pressure. This
reading was read as “MMA with features of achalasia and
IEM.” In this case, barium esophagram failed to reveal the
classic features of achalasia.
Patients were asked to ﬁll out a questionnaire in which
they described their major symptom, which was the reason
for undergoing MII-EM. The symptoms included heart-
burn, dysphagia, regurgitation, chronic cough, chest pain
or pressure, epigastric pain, hoarseness, throat clearing, and
recurrent asthma attacks.
Simple statistics were used to describe manometric and
impedance characteristics in this group of patients. w2 tests
were used to assess diﬀerences in proportion of patients
and/or swallows. Unpaired t tests were used to compare
mean values of diﬀerent diagnostic groups. For statistical
signiﬁcance a was set at 0.05.
RESULTS
Three hundred and ﬁfty patients (223 female, 116
male, mean age: 57.3 y, range 16 to 84 y) underwent
esophageal function testing using HRIM between August
2012 and May 2013. While all patients received liquid
swallows, 46 patients (10 normal manometry, 10 achalasia,
2 DES, 2 nutcracker, 13 IEM, 2 SSc, 3 hypertensive LES, 1
hypotensive LES, 3 MMA) requested discontinuation of
the study before receiving viscous swallows. The primary
symptoms for which patients were referred for esophageal
function testing were: dysphagia (28%), chronic cough
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(15%), chest pain/pressure (12%), heartburn (11%),
regurgitation (11%), epigastric pain (6%), throat clearing
(6%), hoarseness (3%), asthma (3%), and other (6%).
Dysphagia was the primary presenting symptom for
patients diagnosed with achalasia (68%), nutcracker
esophagus (33%), SSc (80%), DES (44%), and hyper-
tensive LES (42%). The primary presenting symptom of
IEM was cough (18%), hypotensive LES was regurgitation
(33%) and cough (33%), and poorly relaxing LES was
chest pain (22%) and cough (22%). Of the 76 patients
presenting with dysphagia who had both liquid and viscous
swallows performed, 28 (37%) had normal bolus transit, 2
FIGURE 1. Major motility abnormality with features of achalasia and ineffective esophageal motility.
FIGURE 2. A, Manometric diagnoses 2012 to 2013. B, Mano-
metric diagnoses 2002 to 2003. DES indicates distal esophageal
spasm; IEM, ineffective esophageal motility; LES, lower esoph-
ageal sphincter; MMA, major motility abnormality; SSc,
scleroderma.
FIGURE 3. Percentage of patients with normal bolus transit for
liquid swallows based on manometric diagnoses. DES indicates
distal esophageal spasm; IEM, ineffective esophageal motility;
LES, lower esophageal sphincter; MMA, major motility abnor-
mality; SSc, scleroderma.
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(3%) had abnormal bolus transit for liquid swallows, 4
(5%) had abnormal bolus transit for viscous swallows, and
42 (55%) had abnormal bolus transit for both liquid and
viscous swallows.
Detailed demographic features of all patients are
shown in Table 1. Patients with IEM, nutcracker, hyper-
tensive LES, and normal manometry were more frequently
women (67%, 92%, 69%, 76%). However, only the prev-
alence of females with nutcracker esophagus was sig-
niﬁcantly diﬀerent from the prevalence of females diag-
nosed with other esophageal abnormalities at the
laboratory (P<0.03). Patients across all categories were
more frequently white; however, no single diagnosis was
signiﬁcantly diﬀerent when compared with patients with
other esophageal abnormalities.
Manometric Findings Using Liquid Swallows
2012 to 2013
Of the 350 patients receiving liquid swallows, 121
(35%) had normal EM. On the basis of the above-men-
tioned manometric criteria, 28 (8%) had achalasia, 5 (1%)
SSc, 110 (31%) IEM, 9 (3%) DES, 12 (3%) nutcracker
esophagus, 26 (7%) hypertensive LES, 6 (2%) hypotensive
LES, 9 (3%) poorly relaxing LES, and 24 (7%) MMA
(Fig. 2A).
Manometric Findings Using Liquid Swallows
2002 to 2003
Ten years ago, of the 350 patients who received liquid
swallows from our laboratory, 125 (36%) had normal EM,
24 (7%) achalasia, 4 (1%) SSc, 71 (20%) IEM, 33 (9%)
DES, 30 (9%) nutcracker esophagus, 25 (7%) hypertensive
LES, 5 (1%) hypotensive LES, and 33 (9%) poorly relaxing
LES (Fig. 2B).
Combined Manometry and Impedance Findings
2012 to 2013
Figure 3 depicts the percentage of patients for each
manometric diagnosis that had normal bolus transit for
liquid swallows. Combined MII-EM for liquid swallows
revealed that none of the patients with achalasia, SSc, or
DES had normal bolus transit. Fifteen percent of patients
with IEM had normal bolus transit, whereas a little over
half of patients with hypertensive LES (57%), hypotensive
LES (60%), and poorly relaxing LES (55%) had normal
liquid bolus transit. Most patients with normal manometry
(83%) and nutcracker esophagus (90%) had normal bolus
transit for liquids.
Combined Manometry and Impedance Findings
2002 to 2003
Our laboratory’s previous study of combined MII-EM
information for liquid swallows showed that none of the
patients with achalasia or SSc had normal bolus transit.
Fifty-one percent of patients with IEM and 55% of patients
with DES had normal bolus transit, whereas almost all
patients with normal EM (95%), nutcracker esophagus
(97%), poorly relaxing LES (100%), hypertensive LES
(96%), and hypotensive LES (100%) had normal liquid
bolus transit.
MMA
Twenty-four patients were diagnosed with MMA. Of
these 24 patients, 9 patients had characteristics of achalasia
and IEM, 7 with achalasia and DES, 3 with SSc and IEM, 2
with achalasia and SSc, 2 with DES and IEM, and 1 with
nutcracker esophagus and DES.
IEM Demographics and Prevalence
One hundred and ten patients with IEM were assessed
using HRIM. Of these patients, 80 (73%) were white and 74
(67%) were female. Of the 97 patients receiving both liquid
and viscous swallows, 11 (11%) patients had mild IEM,
that is, normal bolus transit for liquid and viscous, 24
(25%) patients had moderate IEM with either abnormal
liquid or abnormal viscous bolus transit, and 62 (64%)
patients had severe IEM with abnormal liquid and viscous
bolus transit. The primary symptoms for which IEM
patients were referred for esophageal function testing were
diverse and included: dysphagia (13%), chronic cough
(18%), chest pain/pressure (12%), heartburn (14%),
regurgitation (15%), epigastric pain (8%), throat clearing
(5%), asthma (4%), and other (12%).
DISCUSSION
The results of this study using the HRIM catheter with
the newer conventional diagnostic criteria for IEM and the
nutcracker esophagus update the prevalence of esophageal
abnormalities previously reported from our laboratory 10
years ago.6 Despite the advent of the Chicago Classiﬁcation
System, this study used the conventional diagnostic criteria
to standardize data analysis with our previous study. In the
past decade, the prevalence of normal manometry, acha-
lasia, SSc esophagus, hypertensive LES, and hypotensive
LES have remained the same. However, nutcracker
esophagus, poorly relaxing LES, IEM, and DES show
TABLE 1. Demographic Parameters of all Patients
Diagnosis Patients [n (%)] Female Patients [n (%)] Mean Age Age Range White [n (%)] Black [n (%)]
Normal manometry 121 (35) 91 (76) 56 16-84 63 (72) 22 (25)
Achalasia 28 (8) 14 (50) 61 17-81 22 (79) 6 (21)
SSc 5 (1) 3 (60) 59 49-78 2 (40) 3 (60)
IEM 110 (31) 74 (67) 56 17-82 80 (73) 29 (26)
DES 9 (3) 4 (44) 68 40-83 9 (100) 0 (0)
Nutcracker 12 (3) 11 (92) 57 37-79 8 (67) 3 (25)
Hypertensive LES 26 (7) 18 (69) 59 30-79 19 (73) 5 (19)
Hypotensive LES 6 (2) 4 (67) 52 17-77 6 (100) 0 (0)
Poorly relaxing LES 9 (3) 4 (44) 55 23-75 5 (56) 3 (33)
MMA 24 (7) 12 (50) 62 30-83 16 (67) 7 (29)
DES indicates distal esophageal spasm; IEM, ineﬀective esophageal motility; LES, lower esophageal sphincter; MMA, major motility abnormality; SSc,
scleroderma.
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signiﬁcant changes in prevalence. Likewise, MMA as a
diagnostic category has emerged and accounts for 7% of
diagnoses made from this laboratory.
The data show a decrease in the prevalence of the
nutcracker esophagus from 9% ten years ago to 3% now
(P<0.002). This comes as no surprise as the manometric
criteria for the diagnosis of nutcracker esophagus used in
our laboratory became more stringent in the past 10 years
from an average DEA>180mm Hg to an average
DEA>220mm Hg for the 10 liquid swallows. However, it
should be noted that of our 12 patients diagnosed with
nutcracker esophagus, only 9 were diagnosed by conven-
tional manometry standards. Three patients had DEAs
slightly <220mm Hg, but met Chicago Classiﬁcation
version 2.07 high-resolution manometry requirements
for nutcracker (mean DCI>5000mm Hg s cm). These
observations suggest that perhaps the criteria for “hyper-
contractile esophagus” by HRIM have been set too low and
are consistent with the most recent criterion suggested by
the International Working Group8 as well as a recent study
from our laboratory.9
Likewise, the prevalence of poorly relaxing LES
decreased from 9% to 3% (P<0.0001). With the advent of
high-resolution manometry catheters, the closely spaced
pressure sensors provide a more complete and accurate
assessment of the LES, which essentially eliminates errors
because of sensor placement or LES movement. Con-
sequently, we believe that 3% is a more accurate assessment
of the prevalence of poorly relaxing LES; however, 22 of
the 26 patients diagnosed with hypertensive LES had a
poorly relaxing LES, which could account for the decrease
in prevalence.
Surprisingly, we found an increase in the prevalence of
IEM over the last decade (2004—IEM in 20% of patients,
2014—IEM in 31%; P<0.001) despite the manometric
criteria for IEM becoming more stringent, that is, requiring
5 of 10 instead of 3 of 10 contractions with an amplitude of
<30mm Hg in the distal esophagus. One would have
expected the prevalence to decrease in a similar manner as
the nutcracker esophagus ﬁndings. In addition, in com-
paring the rates of mild, moderate, and severe IEM to a
study from our laboratory done 5 years ago,10 the preva-
lence of severe IEM has increased from 47% to 63%
(P<0.01) among patients found to have IEM. These
ﬁndings suggest that there is an increase in the prevalence as
well as the severity of IEM.
IEM is a frequent motility disorder in patients with
gastroesophageal reﬂux disease (GERD)11 and has been
shown to increase in prevalence as the severity of reﬂux
disease progresses from nonerosive reﬂux disease to erosive
esophagitis to Barrett esophagus.12 The most recent
National Ambulatory Medical Care Survey documented
that the rate of GERD-related doctor visits has nearly
doubled from 1995 to 2006.13 Although it remains unclear
whether GERD is a cause of IEM or vice versa, it is
tempting to consider that the 2 increases in prevalence may
be related. Diabetes, speciﬁcally diabetic autonomic
neuropathy, has also been associated with esophageal
dysmotility, decreased amplitudes of contraction, and
abnormal wave forms.14,15 As diabetes has increased in
prevalence, especially in older adults,16 within the past
decade, it is also another possible explanation for the
increase in IEM prevalence.
Finally, the prevalence of DES has decreased from 9%
to 3% (P<0.0001), whereas neither the manometric
criteria nor the technology have changed in making this
diagnosis. Diﬃcult to catch on manometry testing due to its
sporadic and infrequent occurrence, DES is hard to diag-
nose and even harder to rule out of a diﬀerential. Fur-
thermore, our laboratory has implemented “rule #1,” by
which we believe that it is better to underdiagnose than to
overdiagnose motility abnormalities. Clinical experience
suggests that the term distal esophageal spasm in particular
can often cloud other diagnoses. Consequently, tracings
that suggest DES are examined with additional care to
conﬁrm that every DES diagnosis is strong (ie, borderline
cases are adjusted to normal). Finally, the addition of the
MMA category has captured some of the prior DES
diagnoses.
To compare bolus transit for liquid swallows to the
earlier analysis completed 10 years ago, patients from the
current study who had normal liquid impedance are shown
in Figure 3. These results diﬀer from the data gathered from
our laboratory 10 years ago in 2 ways. First, the earlier
study demonstrated that normal EM, nutcracker esoph-
agus, poorly relaxing LES, hypertensive LES, and hypo-
tensive LES all had normal bolus transit for liquid swallows
in 95% of patients or greater. Although liquid bolus transit
in nutcracker esophagus and hypotensive LES are not sig-
niﬁcantly diﬀerent from 10 years ago, hypertensive LES,
poorly relaxing LES, and normal manometry are all sig-
niﬁcantly diﬀerent (P<0.002). Consequently, this study’s
data do not support the conclusion made in our laboratory
that esophageal body pressures are the main determinants
of complete bolus transit. Instead, the data suggest that
hypertensive LES and poorly relaxing LES can impair
bolus transit in about half of patients. It has been known
that when combined with an esophageal body dysfunction,
the patients’ symptoms stem primarily from the abnor-
mality in LES relaxation and that inadequate LES relaxa-
tion causes delayed esophageal clearance.3 As the majority
of patients from this study who were grouped under
hypertensive LES also had a poorly relaxing LES, further
analysis is needed as to whether both LES abnormalities
result in bolus transit delay.
Although the bolus transit for liquid swallows for
patients with normal manometry is signiﬁcantly diﬀerent
compared with 10 years ago, we believe this is skewed by
the eﬀects of GERD. A recent study by Savarino et al12
found that some patients with severe reﬂux disease pre-
sented with normal manometry and abnormal bolus transit.
As 13 of the 18 (72%) patients with abnormal bolus transit
for liquid swallows and normal manometry had abnormal
reﬂux studies completed in our laboratory as well, we feel
that this supports Savarino and colleague’s study and
deserves future analysis.
Secondly, the prior study showed that half of patients
with IEM (51%) had normal bolus transit for liquids. We
believe the drastic decrease in this number to 15%
(P<0.0001) is indicative of both the change in the IEM
deﬁnition and the rise in prevalence of severe IEM. In
addition, normal bolus transit for liquids in patients with
DES dropped from 55% ten years ago to 0% in the current
study (P<0.01). Consequently, we believe that the
manometric parameters and patterns do not overestimate
the functional defect caused by IEM and DES.
This study is limited by the lack of comparison of the
HRIM to barium studies that could have possibly con-
ﬁrmed or clariﬁed the diagnosis for many of the patients
categorized as MMA. Therefore, we cannot comment on
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the diagnostic accuracy and advantages of MMA as a
diagnostic term. Further analysis of these ﬁndings is the
focus of a subsequent study from our laboratory. In addi-
tion, one could regard the use of conventional manometry
criteria as a further limitation arguing that we missed out
on the chance to use the Chicago classiﬁcation with the
HRIM recordings. As the study published 10 years ago
used the conventional Spechler-Castell classiﬁcation sys-
tem, we considered it more appropriate to use the same
system when evaluating changes in prevalence of mano-
metric ﬁndings over time.
In summary, although most of the “named” esoph-
ageal motility disorders have not changed in prevalence or
have ﬂuctuated in a predictable manner, IEM has sig-
niﬁcantly increased in prevalence and severity. Further
studies are needed to evaluate possible causes for this and
to better clarify the IEM, GERD, and diabetes relationship.
A suggestion is made in support for a new small subclass of
MMA, which we feel has been helpful in our laboratory to
identify the occasional poorly deﬁned but deﬁnitely
abnormal study. The ﬁndings of this investigation also
suggest that a change in the classiﬁcation of esophageal
motility abnormalities which better blends the manometry
and bolus transit may be needed. Further analysis of the
dynamics of the LES in relation to esophageal functional
defects likely deﬁned by HRIM is also needed.
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